| P2093 | author name string | R. Fogari | |
| | G. Villa | |
| | A. Zoppi | |
| | G. D. Malamani | |
| | G. Marasi | |
| | A. Vanasia | |
| P2860 | cites work | Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study | Q33612289 |
| | Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study | Q33612628 |
| | Lowering the plasma fibrinogen concentration with drugs | Q35594814 |
| | Drugs affecting plasma fibrinogen levels | Q36067954 |
| | Management of multiple risk factors for coronary heart disease in patients with hypertension | Q36481334 |
| | Cardiovascular risk factors and their interactions in hypertensives | Q36990759 |
| | Antihypertensive treatment and serum lipoproteins | Q39393667 |
| | Effects of diuretic drugs on the lipid profile | Q39554992 |
| | Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension | Q39591776 |
| | Captopril and hydrochlorothiazide: rationale for their combination | Q39767725 |
| | Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis | Q40279327 |
| | Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 |
| | Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study | Q41206667 |
| | A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension | Q41780967 |
| | Plasma fibrinogen--a major coronary risk factor | Q41879314 |
| | Fibrinogen | Q43162739 |
| | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 |
| | Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease | Q44475158 |
| | The effect of physiological levels of fibrinogen on platelet aggregation | Q44676091 |
| | Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study | Q45174787 |
| | A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors. | Q51624160 |
| | Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 |
| | Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 |
| | Relation between extent of coronary artery disease and blood viscosity. | Q54965703 |
| | Diabetic hypertension--the importance of fibrinogen and blood viscosity | Q68063447 |
| | [Enzymatic determination of total cholesterol in serum (author's transl)] | Q68825859 |
| | Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study | Q68979773 |
| | Analysis of risk factors for stroke in a cohort of men born in 1913 | Q69157828 |
| | Hypertension and other risk factors in coronary heart disease | Q69413835 |
| | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 |
| | Smoking and plasma fibrinogen | Q69912548 |
| | Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension | Q69928901 |
| | Importance of coronary heart disease risk factors in the management of hypertension. An overview | Q69940879 |
| | Effect of fibrinogen concentration on the velocity of platelet aggregation | Q70228766 |
| | Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in angina pectoris before and after propranolol therapy | Q71198538 |
| | Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 |
| | Rheological aspects of cerebrovascular disease | Q71824671 |
| | Essential hypertension. The behaviour of the haemorheological determinants and their trends during beta-blocker treatment | Q72573303 |
| | [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 471-476 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients | |
| P478 | volume | 39 | |